about
Microenvironment, oncoantigens, and antitumor vaccination: lessons learned from BALB-neuT mice.Chimeric DNA Vaccines against ErbB2+ Carcinomas: From Mice to Humans.Early onset and enhanced growth of autochthonous mammary carcinomas in C3-deficient Her2/neu transgenic mice.A hypoxic signature marks tumors formed by disseminated tumor cells in the BALB-neuT mammary cancer model.Immunotargeting of Antigen xCT Attenuates Stem-like Cell Behavior and Metastatic Progression in Breast Cancer.The non-inflammatory role of C1q during Her2/neu-driven mammary carcinogenesis.Cytokine-Induced Killer Cells Kill Chemo-surviving Melanoma Cancer Stem Cells.BRAF and MEK inhibitors increase PD1-positive melanoma cells leading to a potential lymphocyte-independent synergism with anti-PD1 antibody.Multiple roles of perforin in hampering ERBB-2 (Her-2/neu) carcinogenesis in transgenic male mice.Chimeric DNA Vaccines: An Effective Way to Overcome Immune ToleranceCapecitabine and Temozolomide versus FOLFIRI in RAS-Mutated, MGMT-Methylated Metastatic Colorectal Cancer
P50
Q33786788-8212F55E-C7E4-46D3-85EC-5355E0D8D3EDQ37137404-C5B4D6AA-F9DE-4F4E-8BF6-60C3D31CB2A2Q37289084-F4F6E79E-24E3-4596-A3F4-6D61808E865AQ37362844-4CB43594-2773-4D1A-B228-75C9570AE585Q38819633-08EAB018-7CB7-449C-9C15-26395E4DA5ACQ40357845-5A36CEB1-F36F-43F3-95BA-24E7EF023B7BQ51107291-D21D1FC1-F2AF-42F4-BD33-1ABCD063C758Q52719711-321EFAB7-7EA9-43EC-83CC-BC1C3ABB6789Q53238322-776D043D-F78A-40C5-8A51-9F80F42E4894Q61822487-D53FCBA2-480E-4599-B8CE-E6CD31478A3AQ91329177-E8E9F7FF-06B6-47E2-8B56-62EA4DA24C9D
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-1749-7813
@en
name
Marco Macagno
@ast
Marco Macagno
@en
Marco Macagno
@es
Marco Macagno
@nl
type
label
Marco Macagno
@ast
Marco Macagno
@en
Marco Macagno
@es
Marco Macagno
@nl
altLabel
MacAgno, Marco
@nl
prefLabel
Marco Macagno
@ast
Marco Macagno
@en
Marco Macagno
@es
Marco Macagno
@nl
P108
P1153
51663634700
P21
P31
P496
0000-0002-1749-7813